Vitamin B12 and Folinic Acid Supplementation in Mitochondrial DNA Deletion Syndromes

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Mitochondrial DNA DeletionMacrocytosis
Interventions
DIETARY_SUPPLEMENT

Folinic acid (oral); Cyanocobalamin sublingual

"* Vitamin B12 (also known as Cyanocobalamin) daily sublingual supplementation of 1000 mcg/day and folinic acid orally 1mg/day~* Laboratory: Complete blood count, electrolytes, reticulocytes, creatinine, urea, alkaline phosphatase (ALP), alanine transaminase, ferritin, total homocysteine, lactate and hemoglobin A1c. Routine blood will be collected as regular standard of care with each visit. MMA will also be assessed. Peripheral serum values (CBC, B12) will serve as a representation of central micronutrient availability~* Clinical Evaluation: the Newcastle mitochondrial disease adult scale (NMDAS)"

All Listed Sponsors
lead

University of British Columbia

OTHER